首页 | 本学科首页   官方微博 | 高级检索  
     

pN3b期胃癌亚分期预后评估的合理性研究
引用本文:王鹏亮,邓靖宇,孙哲,王玮,王振宁,徐惠绵,周志伟,梁寒. pN3b期胃癌亚分期预后评估的合理性研究[J]. 中国肿瘤临床, 2021, 48(3): 118-124. DOI: 10.3969/j.issn.1000-8179.2021.03.619
作者姓名:王鹏亮  邓靖宇  孙哲  王玮  王振宁  徐惠绵  周志伟  梁寒
作者单位:①.天津医科大学肿瘤医院胃部肿瘤科,国家恶性肿瘤临床医学研究中心,天津市“肿瘤防治”重点实验室(天津市300060)
基金项目:国家自然科学基金资助项目(编号:81572372);国家重点研发计划项目(编号:MOST-2016YFC1303200);国家精准医学研究项目(编号:2017YFC0908300);国家临床重点专科建设项目(编号:2013-544)资助。
摘    要:目的:第8版TNM分期将pN3b期患者纳入分期,这一变化提高了预后评估准确性.然而鲜有研究评价pN3b期患者的预后情况,并且pN3b期病例涵盖的淋巴结转移范围较广,而如此大范围的淋巴结转移患者纳入到同一分期中,其合理性仍属未知.方法:来自国内多中心的642例pN3b期患者纳入本次研究.采用Kaplan-Meier方法及...

关 键 词:胃癌  淋巴结转移  N3b分期  预后
收稿时间:2020-05-27

Proposal of a novel subclassification of pN3b for improving the prognostic discrimination ability of gastric cancer patients
Pengliang Wang,Jingyu Deng,Zhe Sun,Wei Wang,Zhenning Wang,Huimian Xu,Zhiwei Zhou,Han Liang. Proposal of a novel subclassification of pN3b for improving the prognostic discrimination ability of gastric cancer patients[J]. Chinese Journal of Clinical Oncology, 2021, 48(3): 118-124. DOI: 10.3969/j.issn.1000-8179.2021.03.619
Authors:Pengliang Wang  Jingyu Deng  Zhe Sun  Wei Wang  Zhenning Wang  Huimian Xu  Zhiwei Zhou  Han Liang
Affiliation:①.Department of Gastroenterology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China②.Department of Surgical Oncology, The First Hospital of China Medical University, Shenyang 110001, China③.Department of Gastric and Pancreatic Surgery, Sun Yat-Sen University Cancer
Abstract:Objective:In the recent edition of the TNMstaging system,pN3b gastric cancer was subclassified for better prognostic accuracy.pN3b is defined as a large range of metastatic lymph nodes(mLNs).However,few studies have evaluated the prognosis of pN3b patients;furthermore,whether these patients were reasonably assigned to the same substage remains unknown.Methods:In total,642 pN3b patients from a multi-institutional cohort in China were included.Disease-specific survival(DSS)was estimated using the Kaplan-Meier method,and independent prognostic factors were identified using Cox proportional hazards regression analysis.A restricted cubic spine model was used to assess the association between continuous variables and logarithm hazard ratios(HRs).The optimal mLN cut-off value for DSS was identified using the X-tile software.Results:The 5-year DSS rate of the total pN3b cohort was 15.4%.Smooth curves showed a non-linear association between mLNs and logarithm HRs.All pN3b gastric cancer patients were assigned into two subclassifications(pN3b1:16-24 mLNs,pN3b2:≥25 mLNs).A significant survival difference was observed between the two subclassifications(P=0.048).Additionally,the examination of more LNs could bring survival benefit only to pN3b1 patients but not to pN3b2 patients.Conclusions:We proposed a novel subclassification that assigned pN3b patients into two subclassifications with significant survival differences.Future studies should explore prognostic value based on this novel subclassification in the TNM staging system.
Keywords:gastric cancer  lymph node metastasis  N3b stage  prognosis
本文献已被 维普 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号